Antimicrobial resistance in Streptococcus pyogenes isolates in Berlin

被引:29
|
作者
Arvand, M
Hoeck, M
Hahn, H
Wagner, J
机构
[1] Free Univ Berlin, Klinikum Benjamin Franklin, Inst Infektionsmed, D-12203 Berlin, Germany
[2] DRK, Klin Mark Brandenburg, D-13359 Berlin, Germany
关键词
D O I
10.1093/jac/46.4.621
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
A total of 212 clinical Streptococcus pyogenes isolates were tested for susceptibility to various antibiotics by agar dilution. The overall frequency of erythromycin resistance was 12.7%, being higher in isolates from children (18.9%) than in those from adult patients (10.7%). Similar results were found for clarithromycin, while 2.8% of the isolates were resistant to ciprofloxacin. All strains were susceptible to penicillin and cefotaxime. Of the erythromycin-resistant isolates subjected to the double-disc diffusion test for erythromycin and clindamycin, 35% expressed constitutive and 55% inducible resistance to clindamycin. Ten per cent were susceptible to clindamycin (M-phenotype). Thus, a high rate of macrolide resistance in S. pyogenes has emerged in Berlin.
引用
收藏
页码:621 / 623
页数:3
相关论文
共 50 条
  • [1] Antimicrobial resistance of Streptococcus pyogenes clinical strains.
    Rodriguez, RS
    Calderón-Jaimes, E
    Gómez-Barreto, D
    Espinosa-de los Monteros, LE
    [J]. SALUD PUBLICA DE MEXICO, 2000, 42 (03): : 226 - 229
  • [2] Characterization of antimicrobial resistance in Streptococcus pyogenes isolates from the San Francisco Bay area of Northern California
    York, MK
    Gibbs, L
    Perdreau-Remington, F
    Brooks, GF
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (06) : 1727 - 1731
  • [3] Macrolide resistance and erythromycin resistance determinants among Belgian Streptococcus pyogenes and Streptococcus pneumoniae isolates
    Descheemaeker, P
    Chapelle, S
    Lammens, C
    Hauchecorne, M
    Wijdooghe, M
    Vandamme, P
    Ieven, M
    Goossens, H
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (02) : 167 - 173
  • [4] Macrolide-resistance genes in clinical isolates of Streptococcus pyogenes
    Cascone, C
    Santagati, M
    Noviello, S
    Iannelli, F
    Esposito, S
    Pozzi, G
    Stefani, S
    [J]. MICROBIAL DRUG RESISTANCE, 2002, 8 (02) : 129 - 132
  • [5] Erythromycin resistance genes in Streptococcus pyogenes isolates in Kanagawa, Japan
    Murase, T
    Suzuki, R
    Watanabe, Y
    Yamai, S
    [J]. MICROBIOLOGY AND IMMUNOLOGY, 2000, 44 (10) : 863 - 865
  • [6] Antimicrobial resistance amongst isolates of Streptococcus pyogenes and Staphylococcus aureus in the PROTEKT antimicrobial surveillance programme during 1999-2000
    Cantón, R
    Loza, E
    Morosini, MI
    Baquero, F
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 : 9 - 24
  • [7] Circulating serotypes and antimicrobial sensitivity of Streptococcus pyogenes isolates from children in Cyprus
    Koliou, M.
    Ioannou, Y.
    Efstratiou, A.
    Hannidou, N.
    Pieri, V.
    Alexandrou, M.
    Soteriades, E. S.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2007, 13 (06) : 645 - 647
  • [8] Erythromycin Resistance in Streptococcus pyogenes Group A throat isolates in Sukkur city
    Memon, Badaruddin A.
    [J]. RAWAL MEDICAL JOURNAL, 2007, 32 (01):
  • [9] Resistance to macrolides in clinical isolates of Streptococcus pyogenes due to ribosomal mutations
    Malbruny, B
    Nagai, K
    Coquemont, M
    Bozdogan, B
    Tambic Andrasevic, A
    Hupkova, H
    Leclercq, R
    Appelbaum, PC
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 (06) : 935 - 939
  • [10] Survey of macrolide resistance phenotypes in Swedish clinical isolates of Streptococcus pyogenes
    Jasir, A
    Schalén, C
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 41 (01) : 135 - 137